These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8625335)

  • 21. A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
    Kalofonos HP; Nicolaides C; Samantas E; Mylonakis N; Aravantinos G; Dimopoulos MA; Gennatas C; Kouvatseas G; Giannoulis E; Dervenis C; Basdanis G; Pavlidis N; Androulakis I; Fountzilas G;
    Am J Clin Oncol; 2002 Feb; 25(1):23-30. PubMed ID: 11823690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II trial of 5-fluorouracil, leucovorin, and interferon alpha 2A (IFN-alpha 2a) in metastatic pancreatic carcinoma: a Penn Cancer Clinical Trials Group (PCCTG) trial.
    David AK; Vaughn DJ; Holroyde CP; Armstead B; Haller DG
    Am J Clin Oncol; 2000 Feb; 23(1):37-9. PubMed ID: 10683073
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.
    Wilke H; Schmoll HJ; Preusser P; Fink U; Stahl M; Schöber C; Link H; Freund M; Hanauske A; Meyer HJ
    Adv Exp Med Biol; 1988; 244():233-43. PubMed ID: 3073658
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinoma.
    Creagan ET; Veeder MH; Suman VJ; Burch PA; Maples WJ; Schaefer PL; Pfeifle DM; Dalton RJ; Hatfield AK; Poon MA
    Am J Clin Oncol; 1998 Oct; 21(5):475-8. PubMed ID: 9781603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha interferon-2b, leucovorin, and 5-fluorouracil (ALF) in non-small cell lung cancer.
    Quan WD; Casal R; Rosenfeld M; Walker PR
    Cancer Biother Radiopharm; 1996 Aug; 11(4):229-34. PubMed ID: 10851542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A phase II trial of 5-fluorouracil, leucovorin, and recombinant alpha-2b-interferon in advanced adenocarcinoma of the pancreas.
    Scheithauer W; Pfeffel F; Kornek G; Marczell A; Wiltschke C; Funovics J
    Cancer; 1992 Oct; 70(7):1864-6. PubMed ID: 1525760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [New chances in therapy of gastrointestinal tumors].
    Krankenpfl J; 2005; 43(7-10):232. PubMed ID: 16515302
    [No Abstract]   [Full Text] [Related]  

  • 28. A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer.
    Moore MJ; Kaizer L; Erlichman C; Myers R; Feld R; Thiessen JJ; Fine S
    Cancer Chemother Pharmacol; 1995; 37(1-2):86-90. PubMed ID: 7497602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antineoplastic chemotherapy in digestive tumors].
    Bellmunt J; Albanell J; Gallego OS; Vicente P
    Med Clin (Barc); 1991 Sep; 97(9):358. PubMed ID: 1720494
    [No Abstract]   [Full Text] [Related]  

  • 30. Etoposide, leucovorin, 5-fluorouracil and interferon alpha-2b in elderly gastric cancer patients: a pilot study.
    Cascinu S; Fedeli A; Catalano G
    Cancer Chemother Pharmacol; 1994; 34(1):72-4. PubMed ID: 8174205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of unknown primary site--a complete and sustained response with interleukin-2, alpha interferon and 5-fluorouracil/leucovorin.
    Dave HP; White CL; Schulof R; Avis FP
    Acta Oncol; 1992; 31(5):592-3. PubMed ID: 1419108
    [No Abstract]   [Full Text] [Related]  

  • 32. Alpha interferon, leucovorin, and 5-fluorouracil (ALF) in advanced cancer: results of a dose-finding study and evidence of activity in non-small cell lung cancer.
    Quan WD; Madajewicz S; Smith MR; Skeel RT
    Cancer Invest; 1994; 12(4):367-74. PubMed ID: 8032955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized trial of 5-fluorouracil and high-dose folinic acid with or without alpha-2B interferon in advanced colorectal cancer.
    Recchia F; Nuzzo A; Lalli A; Lombardo M; Di Lullo L; Fabiani F; Fanini R; Venturoni L; Torchio P; Peretti G
    Am J Clin Oncol; 1996 Jun; 19(3):301-4. PubMed ID: 8638546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
    Yee LK; Allegra CJ; Steinberg SM; Grem JL
    J Natl Cancer Inst; 1992 Dec; 84(23):1820-5. PubMed ID: 1433371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of 5-fluorouracil plus leucovorin and interferon alpha 2b in advanced colorectal cancer.
    Sobrero A; Nobile MT; Guglielmi A; Mori A; Aschele C; Bolli E; Tixi L; Gallo L; Parodi GC; Bruzzi P
    Eur J Cancer; 1992; 28A(4-5):850-2. PubMed ID: 1524906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
    Tournigand C; Louvet C; de Gramont A; Lucchi E; Seitz JF; Mal F; Raymond E; Cady J; Carola E; Krulik M
    Cancer; 1997 Mar; 79(6):1094-9. PubMed ID: 9070485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer.
    Johnston PG; Mick R; Recant W; Behan KA; Dolan ME; Ratain MJ; Beckmann E; Weichselbaum RR; Allegra CJ; Vokes EE
    J Natl Cancer Inst; 1997 Feb; 89(4):308-13. PubMed ID: 9048835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.
    Jones DV; Samaan NA; Sellin RV; Ajani JA
    Am J Med; 1992 Sep; 93(3):348-9. PubMed ID: 1524091
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase III randomized study of two fluorouracil combinations with either interferon alfa-2a or leucovorin for advanced colorectal cancer. Corfu-A Study Group.
    J Clin Oncol; 1995 Apr; 13(4):921-8. PubMed ID: 7707120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced pancreatic adenocarcinoma with 5-FU, leucovorin, interferon-alpha-2b, and cisplatin.
    Sporn JR; Buzaid AC; Slater D; Cohen N; Greenberg BR
    Am J Clin Oncol; 1997 Feb; 20(1):81-3. PubMed ID: 9020295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.